A54 CONFRONTING AIDS IN WOMEN

A1 PLATELETS STORED FOR 5 DAYS IN A REDUCED PLASMA VOLUME MAINTAIN HEMOSTATIC FUNCTION AND VIABILITY. A2 ROLE OF THE CANADIAN RED CROSS SOCIETY IN THE REGULATION OF BLOOD PRODUCT USE IN CANADA A3 A SURVEY OF CENTRAL ONTARIO HOSPITAL TRANSFUSION POLICIES AND PROCEDURES WHEN INCOMPATIBILITIES ARE DISCOVERED IN CROSSMATCH A4 USE OF SCID MICE IN THE STUDY OF HUMAN IMMUNE RESPONSE AND IN VIVO STABILITY OF HUMAN ANTIBODIES A5 THE USE OF VOLUNTEERS IN THE TRANSFUSION MEDICINE LABORATORY A7 LEUKODEPLETION ––– THE LAST FRONTIER OF TRANSFUSION MEDICINE? A8 PREVENTABLE ASPECTS OF THE PLATELET STORAGE LESION: INCREASE IN SHELF LIFE A9 REFRACTORINESS TO PLATELET TRANSFUSION ASSOCIATED WITH PLATELET‐SPECIFIC ALLOANTIEODIES. A10 GROWTH ENHANCEMENT OF ESTABLISHED TUMOURS BY ALLOGENEIC BLOOD TRANSFUSION (ABT) IN MICE A11 A SURVEY OF ROUTINE METHODS FOR ANTIBODY SCREENING AND CROSSMATCH USED IN CENTRAL ONTARIO HOSPITALS A12 MAXIMUM SURGICAL BLOOD ORDER SCHEDULES FROM 28 HOSPITALS IN CENTRAL ONTARIO A13 DESCRIPTION OF RED CELL TRANSFUSION PRACTICE IN CENTRAL ONTARIO HOSPITALS FOR DISEASES OF THE DIGESTIVE TRACT. A14 SEROLOGIC INVESTIGATION OF NEONATAL THROMBOCYTOPENIA AND POST‐TRANSFUSION PURPURA: EXPERIENCE OF THE MONTREAL CENTRE, CRC. A15 A HOSPITAL BASED AUTOLOGOUS TRANSFUSION PROGRAM A16 A COMPUTERIZED FROZEN BLOOD INVENTORY PROGRAM A17 QUALITY ASSURANCE OF PLATELETS: EVALUATION OF THE SERONO‐BAKER DIAGNOSTICS SYSTEM 9000 DIFF MODEL AUTOMATED CELL COUNTER (BAKER 9000) IN PLATELET ENUMERATION A18 INTERACTION OF TISSUE PLASMINOGEN ACTIVATOR WITH THE ENDOTHELIAL CELL 45 kDa PLASMINOGEN RECEPTOR‐ PLASMODULIN A19 MOLECULAR BIOLOGY OF RED CELL ANTIGENS A20 THE EFFECT OF BIAS WHEN COMPARING METHODS OF ANTIBODY DETECTION A21 CHARACTERIZATION OF THE ASSOCIATION OF HUMAN FACTOR X WITH FACTOR VIII. A22 IMPACT OF CHANGES IN DONOR SELECTION CRITERIA ON DONOR DEFERRALS A23 IMPACT OF REGULATION ON TRANSFUSION MEDICAL PRACTICE A24 ANALYSIS OF PLATELET POPULATIONS OF PLATELET PHERESIS DONORS AND PLATELET CONCENTRATES USING THIAZOLE ORANGE. A25 A COMPARISON OF TWO SOLID PHASE SYSTEMS FOR ANTIBODY DETECTION A26 CYTOMEGALOVIRUS INDUCES INTRACELLULAR PROTEIN PHOSPHORYLATION FOLLOWING BINDING TO HUMAN FIBROBLASTS A27 ENDOTHELIAL CELLS SYNTHESIZE MULTIMERIN AND POSSESS BOTH CONSTITUTIVE AND REGULATED PATHWAYS FOR MULTIMERIN SECRETION A29 STUDIES ON THE PATHOPHYSIOLOGY OF HEPARIN‐INDUCED THROMBOCYTOPENIA. A30 EPITOPE MAPPING OF RECOMBINANT HIV‐1 GAG GENE PRODUCT FOR DEVELOPMENT OF AN ASSAY WITH IMPROVED SPECIFICITY FOR ASSESSMENT OF HIV SEROCONVERSION